Iovance Biotherapeutics (2LB.F) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.42
-0.41
-0.4
-0.39

Details

Expected EPS
-0.39345268400000005
Actual EPS
-0.389424
Surprise EPS
0
Surprise Percent
+1.02%

Description

Iovance Biotherapeutics (2LB.F) has reported earnings of -0.389424 per share for Q2 2024.

0 Comments

Share your thoughts